Bob Langer's first port of call — Polaris Partners — maps $400M for ninth fund

Natalie Grover

Reporter

Health and tech venture group Polaris Partners, which counts Alector, Alnylam and Editas Medicine as part of its portfolio, is setting up its ninth fund …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bob Langer's first port of call — Polaris Partners — maps $400M for ninth fund

Natalie Grover

Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Bob Langer's first port of call — Po­laris Part­ners — maps $400M for ninth fund

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Bob Langer's first port of call — Polaris Partners — maps $400M for ninth fund